News & Events
Hong Kong, 30 October 2026 – China Chengxin (Asia Pacific) Credit Ratings Company Limited (“CCXAP”) has assigned senior unsecured debt rating of Ag+ to the existing CNY bonds (ISIN: XS3509256353) issued by Huaxin Pharmaceutical (Hong Kong) Co., Limited, an indirect wholly-owned subsidiary of Taizhou Guokong Investment Group Co., Ltd. (“TGIG” or the “Company”) (Ag+/Stable), and to be unconditionally and irrevocably guaranteed by TGIG.
Click HERE to download the press release.
CCXAP’s public ratings are available at www.ccxap.com (Rating Results) and may be distributed through media and other means. Methodology used in the rating is the Rating Methodology for China’s Local Infrastructure Investment and Financing Companies dated July 2022. The Methodologies are available at www.ccxap.com (Rating Methodologies).